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Abstract
Background: A delayed post-pancreatoduodenectomy haemorrhage is associated with a significant
increase in peri-operative mortality. Endovascular techniques are frequently used for a delayed
haemorrhage. However, limited data exists on the short- and long-term outcomes of this approach. A
retrospective review over a 10-year period at a quaternary-referral pancreatic centre was performed.
Methods: Between 2002–2012, 1430 pancreatoduodenectomies were performed, and 32 patients had
a delayed haemorrhage (occurring >24 h post-operatively) managed by endovascular techniques. The
clinicopathological variables related to a haemorrhage were investigated.
Results: A total of 42 endovascular procedures were performed at a median of 25 days, with the
majority of delayed haemorrhages occurring after 7 days. There were four deaths (13%) with three
occurring in patients with a grade C haemorrhage. Seven patients (22%) experienced rebleeding, and
two patients developed hepatic abscesses.
Conclusion: A delayed haemorrhage post-pancreaticoduodenectomy can be managed by endovas-
cular techniques with acceptable morbidity and mortality. Rebleeding and hepatic abscesses may
occur and can be managed non-operatively in most cases. The association of a delayed haemorrhage
with a pancreatic fistula makes this a challenging clinical problem.
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Introduction
The peri-operative mortality after a pancreatoduodenectomy
(PD) at high-volume centres in contemporary series is < 3%.1,2
While mortality has decreased, peri-operative complications
including delayed gastric emptying, a pancreatic fistula and
abscesses remain common. In contrast, a post-pancreatectomy
hemorrhage (PPH) occurs less frequently but has been
associated with a significant increase in mortality.3 To facilitate
standardized reporting and study of this complication, the
International Study Group for Pancreatic Surgery (ISGPS) has
proposed a classification system for PPH.4 The definitions
distinguish an early haemorrhage as occurring within 24 h of
the index operation and a late haemorrhage beyond 24 h.
Several recent studies have evaluated the classification system.5–7
These studies indicate that haemorrhage after a PD may occur
in as many as 6–8% of patients. Importantly, there appear to
be clear differences in patient outcomes depending on the tim-
ing and severity of bleeding. For example, in one study,
patients with delayed extraluminal grade C PPH had a mortal-
ity of 41%.6 The studies to date underscore the fact that
delayed bleeding after a PD represents one of the most
challenging and potentially life-threatening post-operative
complications.
In recent years, a delayed post-operative haemorrhage has
been preferentially treated with endovascular techniques. The
use of coil embolization for a gastroduodenal artery stump
haemorrhage and the use of hepatic artery stents are well
described. While these methods are considered highly effective
and avoid the morbidity of a laparotomy, there are limited
data evaluating the potential complications and long-term
This study was presented at the Pancreas Club Meeting, May 17–18,
2013, Lake Buena Vista, Florida.
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outcomes. Given the paucity of data on patients managed by
endovascular techniques for a delayed PPH, we focused
specifically on this population. The aims of this study were
two-fold. First, we sought to identify patients with a delayed
PPH managed with the endovascular approach to assess short-
and long-term outcomes. Second, given the significant increase
in morbidity and mortality, we evaluated potential risk factors
for Grade B and C PPH.
Patients and methods
A retrospective review of a prospectively maintained database
of vascular interventional procedures after pancreatoduodenec-
tomies between January 2002 and November 2012 was
performed at a quaternary-referral pancreatic surgery centre.
Patients undergoing other pancreatic operations including
enucleation, a total pancreatectomy and a distal pancreatec-
tomy were excluded. ISGPS definitions and grading system for
PPH were used. A delayed PPH was defined as a haemorrhage
occurring beyond 24 h post-operatively. Patients with grade A
PPH were clinically well and did not require therapeutic
intervention. Patients with a grade B PPH had a mild, late
intra- or extraluminal haemorrhage requiring intervention that
may include transfusion of blood, intermediate care or
intensive care unit, endoscopy, embolization or relaparotomy
for early PPH. Patients with grade C PPH had severe bleeding,
were critically ill requiring embolization, endoscopy, or a
laparotomy and intensive care unit care. All identified cases of
post-PD haemorrhage managed by interventional radiology
(IR) occurred after 24 h, therefore, by ISGPS definition would
be considered a delayed haemorrhage. Pancreatic fistula was
defined and graded per ISGPS. Cases in which drain amylase
was not available but clinical notes documented a pancreatic
leak and/or management of a leak was described were deemed
grade B or C leaks as appropriate. Clinical variables associated
with bleeding and postoperative management were reviewed.
Operative reports were reviewed; estimated blood loss and
operative time were extracted from the anaesthetic record.
Pathology reports were reviewed to determine the final
pathologic diagnosis.
This study was approved by the Mayo Clinic Institutional
Review Board.
Results
Between 2002 and 2012, 1430 pancreatoduodenectomies were
performed. Thirty-two patients (2%) required endovascular
management of a delayed haemorrhage. The median age of
patients undergoing endovascular management for bleeding
was 62.5 years, and 66% were males (Table 1). The median
body mass index (BMI) was 27.9. Sixty-nine per cent of the
patients underwent an open PD with the remaining undergo-
ing a laparoscopic or robot-assisted PD. All patients underwent
a pancreaticojejunostomy with 77% of these being performed
as a duct-to-mucosa reconstruction. The remaining patients
underwent an end-to-side invaginating or dunking pancreat-
icojejunostomy. The mean operative time was 389 min. Most
patients had a drain placed at the time of operation (81%).
Nine per cent of patients underwent concomitant vein
resection. The pancreatic gland texture was soft in 56% of the
patients. Only 28% of the patients presented with pancreatic
ductal adenocarcinoma and the majority of the pancreatic
Table 1 Patient and operative factors
Variable n (%)
Patients 32
Demographics
Median age 63 (36–82)
Male 21 (66%)
Body mass index 28 (21–36)
Operation, n (%)
Open PD 22 (69%)
22/1197 (1.8%)a
Laparoscopic/Robot
assist PD
10 (31%)
10/233 (4.3%)b
Operative time (minutes), mean 389 (218–696)
Vein resection 3 (9%)
Duct to mucosa anastomosis 24 (77%)
Gland texture, n (%)
Soft 18 (56%)
Firm 8 (25%)
Unknown 6 (19%)
Duct
Small (<5 mm) 24 (75%)
Dilated (>=5 mm) 3 (9%)
Unknown 5 (16%)
Median duct size, mm (range) 3 (1–10)
Intra-operative blood loss, median 500 (100–3100)
Pathology (%)
Adenocarcinoma other (ampullary,
duodenum and CBD)
10 (28%)
PDAC 10 (28%)
Other 12 (38%)
Grade B/C Pancreatic fistula 23 (72%)
Fistula risk score (mean) 5 (2–9)
Use of pancreatic stent 14 (45%)
Use of operative drain 25 (81%)
PD, pancreatoduodenectomy; PDAC, pancreatic ductal adenocarci-
noma; CBD, common bile duct.
a
Number (%) of open PD with a post-pancreatectomy haemorrhage
managed by endovascular techniques.
b
Number (%) of laparoscopic/robotic-assisted PD with a post-pancrea-
tectomy haemorrhage managed with endovascular techniques.
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ducts were noted to be small (<5 mm). Half of the patients
presented with tumours located within the duodenum, ampulla
or common bile duct.
Forty-two endovascular procedures were performed in the
32 patients including 27 embolizations and 14 covered endo-
vascular stents to manage pseudoaneurysms (Table 2). One
patient underwent balloon angioplasty to manage an endoleak
from a previously placed stent. Eight patients (25%) required
repeat intervention. One patient underwent angiography
without active bleeding identified. A bleeding source was
identified on repeat angiography 8 days later. The presentation
was sanguineous drain output 31% of the time, gastrointestinal
(GI) bleeding in 48%, and 12% of the time both intraluminal
and extraluminal bleeding was identified. Eleven patients with
suspected intraluminal bleeding underwent endoscopy prior to
angiography; however, not all patients with luminal bleeding
underwent endoscopy. Patients with both intra-luminal and
extra-luminal bleeding more consistent with pseudoaneurysmal
bleeding were managed by interventional angiography. One of
the patients had a delayed haemorrhage from the pancreat-
icojejunal anastomosis, specifically the cut surface of the
pancreas. Interestingly, 17% of the procedures were performed
in the absence of overt bleeding from the drain or GI tract.
These were noted incidentally when cross-sectional imaging
was performed to assess for intra-abdominal abscesses or
during routine oncological follow-up (Fig. 1).
Endovascular procedures were performed at a median of
25 days after a PD (range 4–68) with 94% occurring after
7 days and 31% occurring after 30 days. Forty-one per cent of
patients had an interventional procedure performed after
hospital discharge after the index operation. Three patients
were transferred from outside institutions where they presented
with anaemia, blood from an operative drain, or gastrointesti-
nal bleeding. The median units of blood transfused were
5 (range 1–25), and 65% of the patients required admission to
a higher level of care (53% intensive care unit). Patients
undergoing endovascular management had a concomitant
pancreatic leak documented in 72% of cases and a median
hospital length of stay of 35 days (range 10–119).
After a median follow-up of 356 days, recurrent bleeding
occurred in 21% of patients after endovascular management.
These were treated with embolization and two patients
ultimately required reoperation. Twenty-one patients had
imaging follow-up beyond 30 days with a median of 329 days
(range 42–2030). Two hepatic abscesses were identified after
embolization or stenting of the hepatic artery, and both were
managed with percutaneous drainage. One focal hepatic infarc-
tion managed without drainage was also identified. Patients
were not anticoagulated after stent placement owing to concern
for re-bleeding and because the majority had bleeding in the
context of other post-operative complications. We did not
identify a delayed haemorrhage attributable to a drainage
procedure for an abscess or fistula. Fifteen patients (47%) had
follow-up beyond 1 year, with a median of 1377 days (range
448–2398). Overall, reoperation was required in 11 (34%) of
which nine patients (82%) underwent reoperation for septic
complications secondary to pancreatic leaks. 72% of the
Table 2 Presentation, endovascular management and outcomes of
a delayed post-pancreatectomy haemorrhage
Variable n (%)
Presentation of bleed
Gastrointestinal bleed 20 (48)
Blood in drain 13 (31)
Both intraluminal/extraluminal 5 (12)
Imaging 4 (10)
Embolization 27 (64)
Stent 14 (33)
Balloon 1 (2)
Involved vessel
CHA/GDA 18 (43)
10 coils (3 recurrent bleed,
1 liver abscess)
8 stent (2 recurrent bleed,
1 liver abscess)
SMA/IPD 14 (33)
8 coils
5 stents (2 recurrent bleed)
1 balloon
Other 10 (24)
Aberrant arterial anatomy 13 (41)
PRBC units transfused 5 (1–25) range
Higher level of care 21 (65)
Recurrent bleed 7 (21)
Recurrent pseudoaneurysm
(CHA, SMA, rRHA)
3
Rebleed from coiled
vessel (GDAx2, rRHA)
2
Blocked CHA stent 1
Endoleak from SMA stent 1
Recurrent bleed interval 10 (2–152) days
Hepatic abscess 2 (6)
In-hospital mortality 4 (13)
Concomitant endoscopy 11 (34)
Intraluminal blood 9
Reoperation 11 (34)
For bleeding 2(6)
Total number of interventional
procedures (mean)
7.7
Length of stay (days) 35 (10–119)
CHA, common hepatic artery; rRHA, replaced right hepatic artery;
GDA, gastroduodenal artery; SMA, superior mesenteric artery; IPD,
inferior pancreatoduodenal artery; PRBC, packed red blood cells.
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reoperations occurred prior to the interventional procedures
for PPH. In the two patients who returned to the operating
room for a recurrent haemorrhage, one had ligation of a bleed-
ing vessel on the cut surface of the pancreas and in the other
the gastroduodenal artery stump was ligated. Overall, there was
a 12.5% mortality rate with four deaths. One death occurred
within 30 days, two occurred within 90-days, and one occurred
beyond 90 days. One patient with a grade B PPH died of
causes unrelated to a pancreatic fistula or haemorrhage. The
remaining three deaths were in patients with grade C PPH.
Two of the deaths were directly related to a haemorrhage
whereas overwhelming sepsis was the cause of death in the
third case. One patient developed a recurrent haemorrhage,
suffered aspiration and after discussion regarding goals of care,
the patient died over 2 months after the index operation. The
other death secondary to a haemorrhage was a prolonged and
complicated post-operative course. The patient had multiple
interventional angiography procedures in the setting of a pan-
creatic fistula, portal vein thrombosis and recurrent haemor-
rhage. The patient developed a massive upper GI bleed and
after discussion regarding the philosophy of care the patient
died over 4 months after the initial PD.
Thirty of the thirty-two patients had grade B or C PPH.
Univariate analyses evaluated potential associations between
patient-related and technical factors and grade of PPH. There
were no significant differences in age, BMI, ASA classification
or type of operation (all P ≥ 0.565). There were no associa-
tions between pancreas-specific factors, such as gland texture,
duct diameter, pathology, estimated blood loss, transfusion
requirement and the development of a grade B versus C PPH
(all P ≥ 0.123). The proportion of grade B and C pancreatic
fistulae did not differ between the two groups (P = 0.657).
Data not shown.
Discussion
A delayed PPH is among the most devastating post-operative
complications after PD. In one review of a prospective database
of 1669 consecutive pancreatic resections, the mortality rate
among patients presenting with a delayed haemorrhage was
nearly 50%.8 Another study of PPH demonstrated a 17-fold
higher mortality in patients with grade C PPH.6 A contemporary
report of management of PPH indicated a lower mortality rate
of 3%. The present study is among the largest to investigate a
haemorrhage managed by interventional techniques post-pan-
creatoduodenectomy. The data presented support the findings of
others that a delayed haemorrhage after a PD is associated with
significant morbidity and increased mortality.
In the present study, the most common presentation for a
delayed haemorrhage was GI bleeding followed by sanguineous
drain output. This finding is consistent with the report of
Correa-Gallego in which an intraluminal haemorrhage was the
presenting sign in 69% of delayed hemorrhages.5 However, the
initial presentation of delayed PPH varies among reports, with
some studies identifying an extraluminal haemorrhage as the
more common initial presentation. The presentation of PPH is
affected by whether an operative drain was placed, as a change
in drain output or character is obviously not detectable upon
removal or in the absence of a drain. Furthermore, a false
intraluminal or extraluminal haemorrhage can occur where, in
the presence of anastomotic dehiscence, extraluminal bleeding
may present intraluminally and vice versa.8
(a)
(b)
(c)
Figure 1 Stenting of incidentally discovered a hepatic artery
pseudoaneurysm. (a) Hepatic artery pseudoaneurysm identified
incidentally on follow-up imaging 6 weeks post-operatively. (b)
Interventional angiography reveals a large pseudoaneurysm from a
replaced hepatic artery. (c) Placement of covered stent in a
replaced hepatic artery
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Others report simultaneous extra- and intra-luminal
bleeding in 7% of cases, which was observed in 12% of our
bleeds.9,10 Interestingly, in the present study, 17% of the
pseudoaneurysms were identified incidentally without overt
signs of a haemorrhage. To our knowledge, this is a novel find-
ing that could be missed by retrospective review of databases
for PPH as there may be no clinical signs of a haemorrhage
documented. Given the potential for pseudoaneurysm rupture,
we strongly recommend intervention even in the absence of
signs of a haemorrhage. Indeed, three patients subsequently
developed clinical signs of haemorrhage including one
pseudoaneurysm adjacent to an existing endovascular stent and
two patients with GI bleeding. Exclusion of four patients who
did not manifest any clinical signs of bleeding during the fol-
low-up yields a PPH incidence of 2%, a re-bleed rate of 25%
and an overall mortality rate of 14%.
Regardless of the mode of presentation, a delayed
haemorrhage occurred many days and even weeks after the
PD. We concur with other groups that the definition of an
early haemorrhage as occurring within 24 h may be too strict
as the pathophysiology and management of bleeding within
the first several postoperative days is unlikely to differ.5,8 In
the present study, the endovascular interventions were
performed a median of 3 weeks after a PD. Almost half of the
patients had been discharged after their index operation. This
finding is consistent with a systematic review that showed a
delayed haemorrhage presenting at a median of 13–27 days
post-operatively.10 Thus, a delayed haemorrhage should be an
important consideration when patients discharged from the
hospital report GI bleeding or sanguineous drainage. Three
patients were transferred from an outside institution after
presenting with signs of bleeding. This study is limited to
patients undergoing IR procedures at our institution. Patients
are routinely followed post-operatively in person or by phone,
and surgical staff are available at all times to respond to
clinical questions from outside institutions. Therefore, the
anticipated number of patients who develop a PPH at an
outside institution that is undocumented would be low. How-
ever, we acknowledge that this study may underestimate the
true incidence of a delayed PPH.
When a delayed haemorrhage is suspected, the subsequent
management remains controversial. This is in contrast to an
early PPH, where most surgeons would advocate for reoperation.
An early haemorrhage is most commonly as a result of inade-
quate or incomplete haemostasis and can be effectively treated
by reoperation. In the setting of a delayed haemorrhage, some
groups advocate for operative intervention, whereas others sup-
port an interventional or endoscopic approach whenever possi-
ble.3,5,8 This is because the operative field after a PD, particularly
when a pancreatic leak is present, may be hostile which may ren-
der access to and control of arterial haemorrhage extremely diffi-
cult. This study supports the findings of others that the majority
of delayed haemorrhages are arterial in origin.8 One patient
underwent stenting of a portal vein pseudoaneurysm. In the
present study, 72% of the patients had a concomitant grade B/C
pancreatic fistula and, thus, a non-operative approach to control
the haemorrhage was given high priority. However, in the
absence of emergent IR services or an unstable patient, some
would argue that reoperation remains the preferred manage-
ment.8 Indeed, in one systematic review, the most common rea-
son for not performing angiography was haemodynamic
instability.10 In the present study, only two patients underwent a
reoperation after a failed angiography. Our study group was lim-
ited to patients undergoing IR; therefore, patients managed
exclusively by reoperation would not have been captured. How-
ever, we anticipate that this number would be small given our
preference to manage a delayed haemorrhage by endovascular
techniques. A specific management pathway or algorithm for
delayed haemorrhage was not used during the study period. In
general, patients presenting with evidence of a delayed extralu-
minal haemorrhage are preferentially managed by endovascular
techniques. In contrast, those that presented with evidence of in-
traluminal bleeding generally undergo endoscopy. CT
angiography is not used for haemodynamically unstable patients.
In our prospectively maintained database, a review of over 1000
consecutive Whipple procedures performed over a 7-year period
from the present centre indicated a reoperation rate of 0.7% for
a haemorrhage (C. Shubert and M. Kendrick, unpublished data).
In the present study, both re-operative cases identified the bleed-
ing source that was successfully controlled. A recurrent
haemorrhage developed in one of these patients. A completion
pancreatectomy has been described in up to 40% of reoperations
for haemorrhage; however, it was not performed in either of
these cases and is not a preferred approach at our institution.8–10
Complications after endovascular management of PPH have
been described. These include rebleeding, stent stenosis or
thrombosis and infarction of end organs secondary to
thrombosis or embolization.11,12 Choi et al.13 describe two
deaths from hepatic failure after hepatic artery embolization
for PPH, whereas Heiss et al.14 described hepatic artery stent
thrombosis without evidence of sequelae. In the present study,
rebleeding was seen in 25% of patients. These were as a result
of recurrent pseudoaneurysms, rebleeding from coiled vessels,
blocked stents and endoleaks. As discussed above, in most
cases these were successfully managed by repeat interventional
procedures. Only two patients developed hepatic abscesses, one
post-embolization of the hepatic artery and one after common
hepatic artery stenting. Both patients were successfully
managed with computed tomography-guided drain placement.
Overall, the present results would indicate an acceptable rate of
morbidity in this complex set of patients. With respect to the
long-term outcomes, our median follow-up for all patients in
the study was 356 days. This makes it difficult to comment on
the long-term durability of this approach, and further study is
required. It should be noted, however, that 47% of the patients
had follow-up beyond 1 year, with a median of nearly 4 years.
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Among these patients, we did not identify long-term sequelae
from the endovascular management of a haemorrhage.
Given the increase in mortality associated with PPH, it
would be valuable to identify risk factors for a haemorrhage.
Furthermore, while there has been a limited evaluation of the
ISGPS grading system, it appears that worsening grade of
haemorrhage correlates with mortality. In one report, the
mortality for patients with grade C PPH was 34% compared
with 6% for grade B PPH.6 Thus, identification of patients at
risk for severe PPH would be clinically relevant. A recent study
identified several factors for grade C PPH, including advanced
age, increased BMI, an intra-operative transfusion, portal
venous resection, multivisceral resection and a post-operative
pancreatic fistula on univariable analysis.7 On multivariable
analysis, a post-operative pancreatic fistula was most strongly
associated with grade C PPH with an odds ratio of 5.6. Several
other studies have also investigated the risk factors for PPH
and the most uniformly associated risk factor among these
studies is a postoperative fistula.15,16 The incidence of a Grade
C fistula was 11 times greater in patients with grade C PPH
and another study reported 55% of post-pancreatoduodenecto-
my hemorrhages had concurrent POPF.6–8 We sought to
identify if risk factors could be identified distinguishing Grade
B and C PPH. As a post-operative pancreatic fistula is strongly
associated with PPH, we included elements of the externally
validated fistula risk score that predict the development of a
post-operative pancreatic fistula.17 We did not find any specific
associations between patient specific or technical factors and
progression to grade B versus a grade C PPH haemorrhage.
This lack of association could be a result of a Type II error
owing to the rarity of the events. The application of the fistula
risk score to a larger population may permit identification of
specific risk factors for a severe haemorrhage.
The pathophysiological relationship between a pancreatic
fistula and haemorrhage is unclear. The role of pancreatic
enzymes, infection and inflammatory mediators to the process
that predisposes to bleeding remains undetermined. It has not
been the routine practice at our institution to protect vessels,
however, in the absence of routinely identifiable risk factors for
a severe haemorrhage, the use of vascularized pedicle flaps to
cover exposed vessels may be considered.18,19
Of 1430 pancreatoduodenectomies performed over a recent
10-year period, 32 patients (2%) required endovascular
management of a delayed haemorrhage. The incidence of a
PPH managed with endovascular techniques was 4.3% after a
laparoscopic PD and 1.8% after an open PD (Table 1). This dif-
ference is noteworthy but beyond the scope of this manuscript
and will be the subject of future investigations. A delayed PPH
was associated with a pancreatic fistula in 72% and resulted in a
mortality rate of 12%. Endovascular procedures were performed
a median of 25 days after a PD, and almost one-half of the
patients had been discharged from the hospital after their pan-
creatic resection. A high index of suspicion for PPH should be
maintained well beyond discharge for the index procedures.
While rebleeding occurred in 22% of the patients, repeat angio-
graphic procedures were successful in managing the majority. It
was noteworthy that 17% of the procedures were performed
based on abdominal computed tomography findings without
clinical evidence of intra- or extraluminal bleeding. While the
median follow-up was 1 year, almost half of the patients had a
median follow-up of nearly 4 years without long-term sequelae
of endovascular management of a haemorrhage.
A delayed haemorrhage after a PD remains one of the most
challenging ongoing clinical problems. The patients frequently
require coordinated care, multiple procedures and a prolonged
stay in the hospital. However, in the majority of cases, a
delayed haemorrhage after a PD can be successfully managed
with endovascular techniques with low morbidity and
acceptable mortality. Further investigation is required to define
risk factors for a severe haemorrhage.
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